Rapid and transient upregulation of BDNF reversed or blocked atrophy and cell loss in patients with depression, and it may be a critical component in subanesthetic intravenous ketamine’s antidepressant actions (Haile et al., 2014). This evidence concerns the gene BDNF and depressive disorder.